SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share (SGMOQ)

Q: What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share in Q3 2024?

100 institutional investors reported SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 800677106

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock, par value $0.01 per share
Total 13F shares: 55,892,914
Total 13F value: $48,377,748
Share change: -29,872,822
Put/Call ratio: 203%
SEC-reported price per share: $0.87
Number of holders: 100
Value change: -$13,237,737
Number of buys: 38
Number of sells: 72
Shares outstanding: 414,294,446

Security key

800677106

Report period

Q3 2024

Institutions

100

Top holders

SGMOQ full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 SANGAMO THERAPEUTICS, INC SEC filings SANGAMO THERAPEUTICS, INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 800677106

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOGEN INC.

Disclosed value leader

WASATCH ADVISORS LP

Comparable rows

0/15

Latest evidence

30 Jun 2024

3/4/5 13F Highest disclosed value: $7,198,451 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WASATCH ADVISORS LP has the largest disclosed position value at $7.2M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WASATCH ADVISORS LP's linked filing trail.

Disclosed position value Top 5

BIOGEN INC. $6.75M

WASATCH ADVISORS LP $7.2M

ARMISTICE CAPITAL, LLC $5.04M

VANGUARD GROUP INC $4.26M

BlackRock Finance, Inc. $1.69M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOGEN INC.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$6,745,007 17,652,466 shares	—	26 Sep 2023
WASATCH ADVISORS LP	13F Company 13F	— denominator unverified	$7,198,451 20,090,570 shares	—	30 Jun 2024
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$5,037,698 14,060,000 shares	—	30 Jun 2024
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$4,263,202 11,898,417 shares	—	30 Jun 2024
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$1,685,063 4,702,938 shares	—	30 Jun 2024
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$1,633,000 4,560,770 shares	—	30 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

100

55,892,914

Rows available

100

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

126

Q3 2024 holders

100

Holder diff

-26

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend